-
Something wrong with this record ?
Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells
R. Vrzal, S. Gerbal-Chaloin, P. Maurel, Z. Dvorák,
Language English Country United States
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Enzyme Activation MeSH
- Cell Cycle drug effects MeSH
- Time Factors MeSH
- Dexamethasone metabolism MeSH
- Extracellular Signal-Regulated MAP Kinases metabolism MeSH
- Microscopy, Fluorescence MeSH
- HeLa Cells MeSH
- Hepatocytes drug effects metabolism ultrastructure MeSH
- Colchicine pharmacology MeSH
- Humans MeSH
- Ligands MeSH
- Microtubules drug effects ultrastructure MeSH
- Tubulin Modulators pharmacology MeSH
- Cell Proliferation drug effects MeSH
- Flow Cytometry MeSH
- Receptors, Glucocorticoid metabolism physiology MeSH
- Signal Transduction drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
We have recently demonstrated that the alkaloid colchicine (COL) inhibits glucocorticoid receptor (GR) transcriptional activity. In addition, we described proteasome-mediated degradation of GR in COL-treated HeLa cells. While these effects were previously attributed to cell cycle arrest in G2/M phase, this explanation is not applicable for nonproliferating cells such as human hepatocytes (HH). In the current study, we compared COL-mediated microtubule disruption and cell cycle arrest with selected GR functions in HeLa cells and HH as models of proliferating and quiescent cells, respectively. Microtubule disruption led to irreversible decrease in GR binding capacity and protein level in HeLa cells. None of the parameters was restored 24 hours after COL withdrawal. In contrast, dexamethasone (DEX) binding was increased in HH at the beginning of the treatment, with following transient activation of extracellular signal-regulated kinase (ERK). The findings of these investigations emphasize the GR-signaling differences between primary and transformed cells.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025732
- 003
- CZ-PrNML
- 005
- 20121207110727.0
- 007
- ta
- 008
- 120817s2010 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1177/1091581810366486 $2 doi
- 035 __
- $a (PubMed)20448266
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vrzal, Radim $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University Olomouc, Slechtitelů 11, Olomouc, Czech Republic. radim.vrzal@email.cz
- 245 10
- $a Comparative effects of microtubules disruption on glucocorticoid receptor functions in proliferating and quiescent cells / $c R. Vrzal, S. Gerbal-Chaloin, P. Maurel, Z. Dvorák,
- 520 9_
- $a We have recently demonstrated that the alkaloid colchicine (COL) inhibits glucocorticoid receptor (GR) transcriptional activity. In addition, we described proteasome-mediated degradation of GR in COL-treated HeLa cells. While these effects were previously attributed to cell cycle arrest in G2/M phase, this explanation is not applicable for nonproliferating cells such as human hepatocytes (HH). In the current study, we compared COL-mediated microtubule disruption and cell cycle arrest with selected GR functions in HeLa cells and HH as models of proliferating and quiescent cells, respectively. Microtubule disruption led to irreversible decrease in GR binding capacity and protein level in HeLa cells. None of the parameters was restored 24 hours after COL withdrawal. In contrast, dexamethasone (DEX) binding was increased in HH at the beginning of the treatment, with following transient activation of extracellular signal-regulated kinase (ERK). The findings of these investigations emphasize the GR-signaling differences between primary and transformed cells.
- 650 _2
- $a buněčný cyklus $x účinky léků $7 D002453
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kolchicin $x farmakologie $7 D003078
- 650 _2
- $a dexamethason $x metabolismus $7 D003907
- 650 _2
- $a aktivace enzymů $7 D004789
- 650 _2
- $a extracelulárním signálem regulované MAP kinasy $x metabolismus $7 D048049
- 650 _2
- $a průtoková cytometrie $7 D005434
- 650 _2
- $a HeLa buňky $7 D006367
- 650 _2
- $a hepatocyty $x účinky léků $x metabolismus $x ultrastruktura $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a fluorescenční mikroskopie $7 D008856
- 650 _2
- $a mikrotubuly $x účinky léků $x ultrastruktura $7 D008870
- 650 _2
- $a receptory glukokortikoidů $x metabolismus $x fyziologie $7 D011965
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a modulátory tubulinu $x farmakologie $7 D050257
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gerbal-Chaloin, Sabine
- 700 1_
- $a Maurel, Patrick
- 700 1_
- $a Dvorák, Zdenĕk
- 773 0_
- $w MED00006203 $t International journal of toxicology $x 1092-874X $g Roč. 29, č. 3 (2010), s. 326-35
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20448266 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207110802 $b ABA008
- 999 __
- $a ok $b bmc $g 947774 $s 783078
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 29 $c 3 $d 326-35 $i 1092-874X $m International journal of toxicology $n Int J Toxicol $x MED00006203
- LZP __
- $a Pubmed-20120817/10/03